Pneumococcal conjugate second or third-dose vaccines (PCVc) in St. Kitts and Nevis
St. Kitts and Nevis: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 0.0% in 2025. ▬ Flat
Latest (2025)
0.0%
World rank
165th
of 192 countries
All-time high
0.0%
in 2008
All-time low
0.0%
in 2008
Years of data
18
2008–2025
Pneumococcal conjugate second or third-dose vaccines (PCVc) in St. Kitts and Nevis, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) in St. Kitts and Nevis is 0.0%, measured in 2025. That is the highest value across all 18 years on record.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in St. Kitts and Nevis peaked at 0.0% in 2008 and was at its lowest, 0.0%, in 2008.
St. Kitts and Nevis ranks 165th of 192 countries on this measure, in the bottom quarter.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 0.0% | 0.0% | 0.0% | 10 |
| 2020s | 0.0% | 0.0% | 0.0% | 6 |
Countries ranked near St. Kitts and Nevis
- 162 Somalia 20.0% compare
- 163 Belarus, Republic of 16.0% compare
- 164 Maldives 2.0% compare
- 165 Egypt, Arab Republic of 0.0% compare
- 165 Czech Republic 0.0% compare
- 165 Estonia, Republic of 0.0% compare
- 165 Austria 0.0% compare
- 165 Vietnam 0.0% compare
- 165 Monaco 0.0% compare
- 165 Ukraine 0.0% compare
- 165 St. Vincent and the Grenadines 0.0% compare
- 165 Democratic People’s Republic of Korea 0.0% compare
- 165 Guinea 0.0% compare
- 165 Sri Lanka 0.0% compare
- 165 Jordan 0.0% compare
- 165 St. Lucia 0.0% compare
- 165 Antigua and Barbuda 0.0% compare
- 165 Gabon 0.0% compare
- 165 Grenada 0.0% compare
- 165 China, People's Republic of 0.0% compare
- 165 Comoros, Union of the 0.0% compare
- 165 Cabo Verde 0.0% compare
- 165 Syrian Arab Republic 0.0% compare
- 165 Jamaica 0.0% compare
- 165 Venezuela, República Bolivariana de 0.0% compare
- 165 Equatorial Guinea, Republic of 0.0% compare
- 165 Thailand 0.0% compare
- 165 Dominica 0.0% compare
- 165 Brunei Darussalam 0.0% compare
- 165 Bosnia and Herzegovina 0.0% compare
More health data for St. Kitts and Nevis
- Un projection of annual infant deaths, annual growth rate -100 % change on previous year (2094)
- Heat deaths vs projected death rates, annual growth rate -0.2397 % change on previous year (2090)
- Heat deaths vs projected death rates 1,623 (2090)
- Un projection of annual infant deaths 0 (2100)
- Deaths in armed conflicts by country 0 (2026)
- Deaths in armed conflicts by region 0 (2026)
- Age population, age 25, male, interpolated 342 (2025)
- Age population, age 25, female, interpolated 368 (2025)
- Age population, age 24, male, interpolated 323 (2025)
- Age population, age 24, female, interpolated 346 (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in St. Kitts and Nevis?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in St. Kitts and Nevis was 0.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in St. Kitts and Nevis?
- The highest recorded value was 0.0% in 2008.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in St. Kitts and Nevis?
- The lowest recorded value was 0.0% in 2008.
- How does St. Kitts and Nevis rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- St. Kitts and Nevis ranks 165th out of 192 countries with data for 2025.
- Where does this St. Kitts and Nevis data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).